Inventor
LIANG MEINA
US22 patents
⚠️ This page may combine multiple inventors who share the name “LIANG MEINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
9 patentsUS6207665B1Mar 27, 2001
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG89 citations98
US6555537B2Apr 29, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG24 citations92
US6534509B1Mar 18, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG19 citations92
US7220856B2May 22, 2007
Substituted quinoline CCR5 receptor antagonists
SCHERING AG22 citations89
US6541476B1Apr 1, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG3 citations73
US7268140B2Sep 11, 2007
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6977258B2Dec 20, 2005
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6972290B2Dec 6, 2005
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6573266B1Jun 3, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
MEDIMMUNE LTD
4 patentsUS10829557B2Nov 10, 2020
Anti-B7-H1 antibodies for treating tumors
MEDIMMUNE LTD2 citations69
US10336823B2Jul 2, 2019
Anti-B7-H1 antibodies for treating tumors
MEDIMMUNE LTD3 citations69
US11827706B2Nov 28, 2023
Anti-B7-H1 antibodies for treating tumors
MEDIMMUNE LTD0 citations59
US11613580B2Mar 28, 2023
Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritis
MEDIMMUNE LTD0 citations51